Barkun A - Search Results

1

High-dose vs non-high-dose PPIs after endoscopic treatment in patients with bleeding peptic ulcer: current evidence is insufficient to claim equivalence.

Calvet X, Barkun A, Bardou M, Sung J, Kuipers EJ. Calvet X, et al. Among authors: barkun a. Arch Intern Med. 2010 Oct 11;170(18):1698-9; author reply 1700. doi: 10.1001/archinternmed.2010.359. Arch Intern Med. 2010. PMID: 20937933 No abstract available.

2

Cost-effectiveness of routine endoscopic biopsies for Helicobacter pylori detection in patients with non-ulcer dyspepsia.

Makris N, Crott R, Fallone CA, Bardou M, Barkun A. Makris N, et al. Among authors: barkun a. Gastrointest Endosc. 2003 Jul;58(1):14-22. doi: 10.1067/mge.2003.295. Gastrointest Endosc. 2003. PMID: 12838214

3

The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence.

Rahme E, Barkun AN, Toubouti Y, Bardou M. Rahme E, et al. Gastroenterology. 2003 Aug;125(2):404-12. doi: 10.1016/s0016-5085(03)00880-1. Gastroenterology. 2003. PMID: 12891542

4

Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease.

Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Romagnuolo J, et al. Ann Intern Med. 2003 Oct 7;139(7):547-57. doi: 10.7326/0003-4819-139-7-200310070-00006. Ann Intern Med. 2003. PMID: 14530225

5

Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding.

Barkun A, Bardou M, Marshall JK; Nonvariceal Upper GI Bleeding Consensus Conference Group. Barkun A, et al. Ann Intern Med. 2003 Nov 18;139(10):843-57. doi: 10.7326/0003-4819-139-10-200311180-00012. Ann Intern Med. 2003. PMID: 14623622 Free article.

6

High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.

Barkun AN, Herba K, Adam V, Kennedy W, Fallone CA, Bardou M. Barkun AN, et al. Aliment Pharmacol Ther. 2004 Mar 1;19(5):591-600. doi: 10.1046/j.1365-2036.2004.01808.x. Aliment Pharmacol Ther. 2004. PMID: 14987328 Free article.

7

The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding.

Barkun AN, Herba K, Adam V, Kennedy W, Fallone CA, Bardou M. Barkun AN, et al. Aliment Pharmacol Ther. 2004 Jul 15;20(2):195-202. doi: 10.1111/j.1365-2036.2004.02035.x. Aliment Pharmacol Ther. 2004. PMID: 15233700 Free article. Review.

8

Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs.

Rahme E, Barkun AN, Adam V, Bardou M. Rahme E, et al. Drug Saf. 2004;27(13):1019-42. doi: 10.2165/00002018-200427130-00004. Drug Saf. 2004. PMID: 15471508 Review.

9

Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidence.

Bardou M, Barkun AN, Ghosn J, Hudson M, Rahme E. Bardou M, et al. Clin Gastroenterol Hepatol. 2004 Oct;2(10):880-7. doi: 10.1016/s1542-3565(04)00389-1. Clin Gastroenterol Hepatol. 2004. PMID: 15476151

10

Meta-analysis: proton-pump inhibition in high-risk patients with acute peptic ulcer bleeding.

Bardou M, Toubouti Y, Benhaberou-Brun D, Rahme E, Barkun AN. Bardou M, et al. Among authors: barkun an. Aliment Pharmacol Ther. 2005 Mar 15;21(6):677-86. doi: 10.1111/j.1365-2036.2005.02391.x. Aliment Pharmacol Ther. 2005. PMID: 15771753 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters